BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8029313)

  • 1. PINV--topography and primary negative symptoms in chronic schizophrenia.
    Eikmeier G; Lodemann E
    Pharmacopsychiatry; 1994 Mar; 27(2):63-4. PubMed ID: 8029313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered fronto-central PINV topography and the primary negative syndrome in schizophrenia.
    Eikmeier G; Lodemann E; Olbrich HM; Pach J; Zerbin D; Gastpar M
    Schizophr Res; 1993 Jan; 8(3):251-6. PubMed ID: 8435386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postimperative negative variation and skin conductance response in chronic DSM-III-R schizophrenia.
    Eikmeier G; Lodemann E; Olbrich HM; Pach J; Zerbin D; Gastpar M
    Acta Psychiatr Scand; 1992 Nov; 86(5):346-50. PubMed ID: 1485524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.
    Kathmann N; Wagner M; Rendtorff N; Engel RR
    Biol Psychiatry; 1995 May; 37(10):754-7. PubMed ID: 7640331
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia.
    Umbricht DS; Bates JA; Lieberman JA; Kane JM; Javitt DC
    Biol Psychiatry; 2006 Apr; 59(8):762-72. PubMed ID: 16497277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Negative schizophrenic symptomatology and the P 300 potential].
    Drouet A; Hort-Legrand C; Féline A; Métral S
    Encephale; 1993; 19(3):229-35. PubMed ID: 8275908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contingent negative variation (CNV) and determinants of the post-imperative negative variation (PINV) in schizophrenic patients and healthy controls.
    Klein C; Rockstroh B; Cohen R; Berg P
    Schizophr Res; 1996 Aug; 21(2):97-110. PubMed ID: 8873777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics of chronic schizophrenic patients presenting with severe anhedonia].
    Loas G; Noisette C; Legrand A; Boyer P; Delahousse J
    Encephale; 1996; 22(5):351-8. PubMed ID: 9035991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Event-related potentials during rule processing in schizophrenia.
    Posada A; Zalla T; Vianin P; Georgieff N; Franck N
    Psychiatry Res; 2005 Mar; 134(1):55-66. PubMed ID: 15808290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow-up dynamics of schizophrenic diseases in adolescence].
    Schulz E; Martin M; Remschmidt H
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):262-74. PubMed ID: 7856322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topography of CNV and PINV in schizotypal personality.
    Klein C; Andresen B; Berg P; Krüger H; Rockstroh B
    Psychophysiology; 1998 May; 35(3):272-82. PubMed ID: 9564747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative difference (Nd), an ERP marker of stimulus relevance: different lateral asymmetries for paranoid and nonparanoid schizophrenics.
    Oades RD; Zerbin D; Eggers C
    Pharmacopsychiatry; 1994 Mar; 27(2):65-7. PubMed ID: 8029314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Event-related potential correlates of linguistic information processing in schizophrenics.
    Strandburg RJ; Marsh JT; Brown WS; Asarnow RF; Guthrie D; Harper R; Yee CM; Nuechterlein KH
    Biol Psychiatry; 1997 Oct; 42(7):596-608. PubMed ID: 9376456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in semantic information processing in schizophrenics.
    Volz HP; Mackert A; Frick K; Bücker U
    Pharmacopsychiatry; 1994 Mar; 27(2):59-62. PubMed ID: 7913235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and relationships between trait or state anhedonia and schizophrenic symptoms in schizophrenia: a 13-year follow-up study.
    Loas G; Monestes JL; Ingelaere A; Noisette C; Herbener ES
    Psychiatry Res; 2009 Apr; 166(2-3):132-40. PubMed ID: 19272653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scalp distribution of slow cortical potentials in schizophrenic patients.
    Rockstroh B; Müller M; Klein C
    Pharmacopsychiatry; 1994 Mar; 27(2):54-8. PubMed ID: 8029312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anhedonia in schizophrenia].
    Loas G; Boyer P; Legrand A; Gayant C; Delahousse J
    Encephale; 1995; 21(6):453-7. PubMed ID: 8674470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.